Kadri Murat GURSES, Utku OGAN AKYİLDİZ, Asli AKYOL GURSES

Routine hematological parameters do not reflect disease severity and cardiovascular risk in obstructive sleep apnea syndrome

AbstractAim: Obstructive sleep apnea syndrome (OSAS) is characterized by transient obstruction of the upper airway and intermittent hypoxia during sleep and known to co-exist with a background low-grade systemic inflammation. In this study, we aimed to evaluate the routine hematological parameters which have recently been suggested as alternatives to specific inflammatory biomarkers and their association with disease severity and concurrent cardiovascular risk factors in OSAS.Material and Methods: 210 patients, who were examined for sleep disordered breathing complaints and diagnosed OSAS after overnight polysomnography, were included in the study. Patients who suffer from at least one of the following disorders; diabetes mellitus, hypertension and hyperlipidemia were classified as “patients with cardiovascular risk”. Results of routine hemogram studies and polysomnographic analyses were recorded.Results: 71% of the patients were male and 29% were female. 12% of the patients had mild, whereas 29% had moderate and 59% had severe obstructive sleep apnea syndrome. Platelet counts, mean platelet volume, platelet distribution width, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio revealed no difference among three groups of disease severity. Comparison of patients with and without cardiovascular risk either showed no difference in terms of the aforementioned parameters.Conclusion: Our findings indicate that routine hematological parameters such as mean platelet volume, platelet distribution width, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are not appropriate indices for predicting disease severity and cardiovascular risk in OSAS patients. As severe disease corresponds to a worse inflammatory state, these markers might not be appropriate for predicting systemic inflammation either.

PDF

___

1. Berry RB, Lee-Chiong T, Marcus C, et al. Sleep Related Breathing Disorders. In: Sateia M, ed. International Classification of Sleep Disorders. 3rd edition. Darien, IL: American Academy of Sleep Med 2014;53-62.
2. Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 2015 ;3:310-8.
3. Baguet JP, Nadra M, Barone-Rochette G, et al. Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea. Vasc Health Risk Manag 2009;5:1063-73.
4. Sekosan M, Zakkar M, Wenig BL, et al. Inflammatio in the uvula mucosa of patients with obstructive sleep apnea. Laryngoscope 1996;106:1018-20.
5. Bergeron C, Kimoff J, Hamid Q. Images in allergy and immunology: obstructive sleep apnea syndrome and inflammation. J Allergy ClinImmunol 2005;116:1393-6.
6. Puig F, Rico F, Almendros I, et al. Vibration enhances interleukin-8 release in a cell model of snoring induced airway inflammation. Sleep 2005;28:1312-6.
7. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea; Overlaps in patophysiology, systemic inflammation and cardiovascular disease. Am J Respir Crit Care Med 2009;180:692-700.
8. Kent BD, Ryan S, McNicholas WT. Obstructive sleep apnea and inflammation: Relationship to cardiovascular co-morbidity. Respiratory Physiology & Neurobiology 2011;178:475-81.
9. Williams A, Scharf SM. Obstructive sleep apnea, cardiovascular disease and inflammation – is NF-kB the key? Sleep Breath 2007;11:69-76.
10. Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009;33:1195-205.
11. Nadeem R, Molnar J, Madbouly EM, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013;9:1003-12.
12. Wu M, Zhou L, Zhu D, et al. Hematological indices as simple, inexpensive and practical severity markers of obstructive sleep apnea syndrome: a meta-analysis. J Thorac Dis 2018;10:6509-21.
13. Bressi E, Mangiacapra F, Ricottini E, et al. Impact of Neutrophil-to-Lymphocyte Ratio and Plateletto-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention. J Cardiovasc Transl Res 2018;11:517-23.
14. Altintas N, Çetinoğlu E, Yuceege M, et al. Neutrophilto-lymphocyte ratio in obstructive sleep apnea; a multi center, retrospective study. Eur Rev Med Pharmacol Sci 2015;19:3234-40.
15. Uygur F, Tanriverdi H, Aktop Z, et al. The neutrophilto-lymphocyte ratio in patients with obstructive sleep apnoea syndrome and its relationship with cardiovascular disease. Heart Lung 2016;45:121-5.
16. Varol E, Ozturk O, Gonca T, et al. Mean platelet volume is increased in patients with severe obstructive sleep apnea. Scand J Clin Lab Invest 2010;70:497-502.
17. Song YJ, Kwon JH, Kim JY, et al. The platelet-tolymphocyte ratio reflects the severity of obstructive sleep apnea syndrome and concurrent hypertension. Clin Hypertens 2016;22:1.
18. Koseoglu HI, Altunkas F, Kanbay A, et al. Plateletlymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. J Thromb Thrombolysis 2015;39:179-85.
19. Sökücü SN, Ozdemir C, Dalar L, et al. Is mean platelet volume really a severity marker for obstructive sleep apnea syndrome without comorbidities? Pulm Med 2014; 2014:754839.
20. Koseoglu S, Ozcan KM, Ikinciogullari A, et al. Relationship Between Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Obstructive Sleep Apnea Syndrome. Adv Clin Exp Med 2015;24:623-7.
21. Korkmaz M, Korkmaz H, Kucuker F, et al. Evaluation of the association of sleep apnea-related systemic inflammation with CRP, ESR, and neutrophil-tolymphocyte ratio. Med Sci Monit 2015;21:477-81.
22. Catapano AL, Graham I, De Backer G. et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 2016;253:281-344.
23. Berry RB, Marcus CL, Parthasarathy S, et al. Respiratory Rules. In: Berry RB, Brooks R, Gamaldo CE, et al. eds. The AASM Manual for the Scoring of Sleep and Associated Events. Rules, Terminology and Technical Specifications, Darien, IL: American Academy of Sleep Med 2017;56-61.
24. American Academy of Sleep Medicine Task Force. Sleep related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999:22:667-89.
25. Faraut B, Boudjeltia KZ, Vanhamme L, et al. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev 2012;16:137-49.
26. Bhat T, Teli S, Rijal J, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013;11:55-9.
27. Jagroop IA, Clatworthy I, Lewin J, et al. Shape change in human platelets: measurement with a channelyzer and visualisation by electron microscopy. Platelets 2000;11:28-32.
28. Vagdatli E, Gounari E, Lazaridou E, et al. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 2010;14:28-32.
29. Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994;89:1951-7.
30. Von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo .Eur J Haematol 2000;65:357-69.
31. Dunleavy M, Dooley M, Cox D, et al. Chronic intermittent asphyxia increases platelet reactivity in rats. ExpPhysiol 2005;90:411-6.
32. Nena E, Papanas N, Steiropoulos P, et al. Mean Platelet Volume and Platelet Distribution Width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets 2012;23:447-54.
33. Kurt OK, Yildiz N. The importance of laboratory parameters in patients with obstructive sleep apnea syndrome. Blood Coagul Fibrinolysis 2013;24:371-4.